𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primer on the rheumatic diseases

Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
37 KB
Volume
20
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Apheresis biotechnology and the rheumati
Apheresis biotechnology and the rheumatic diseases
✍ John H. Klippel πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 476 KB πŸ‘ 1 views

Apheresis, a child spawned by technology and nourished by publicity, is still in its infancy as a treatment for rheumatic diseases. Despite occasional prodigious displays, it is more often unpredictable, costly, and applied without proper concern for the complexities of the procedure. A measure of t

Health disparities in the rheumatic dise
Health disparities in the rheumatic diseases
✍ Escalante, AgustΓ­n πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 1 views

Health care expenditures in the US reached $1.877 trillion in 2004, or 15% of the country's gross domestic product. On a per-capita basis, the US spent $5,635 on health care in 2003, more than any other nation (1). Despite these figures, some groups in the population receive less health care and hav

Marrow Granulocyte Reserves in the Rheum
Marrow Granulocyte Reserves in the Rheumatic Diseases
✍ Harry R. Kimball; Sheldon M. Wolff; Norman Talal; Paul H. Plotz; John L. Decker πŸ“‚ Article πŸ“… 1973 πŸ› John Wiley and Sons 🌐 English βš– 467 KB πŸ‘ 1 views

## Abstract Marrow granulocyte reserves, as measured by the administration of etiocholanolone, were studied in 59 patients with a variety of rheumatic diseases. The majority of patients with systemic lupus erythematosus (62%) and all patients with chronic hepatitis and Felty's syndrome tested had a